AstraZeneca (AZNL)

10,722.00p
   
  • Change Today:
    -54.00p
  • 52 Week High: 13,250.00
  • 52 Week Low: 9,642.00
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 149,738
  • Market Cap: £135,544m

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
Revenue 54,073.00 45,811.00 44,351.00 37,417.00 26,617.00
Operating Profit/(Loss) 10,003.00 8,193.00 3,757.00 1,056.00 5,162.00
Profit Before Tax 8,691.00 6,899.00 2,501.00 (265.00) 3,916.00
Profit After Tax 7,041.00 5,961.00 3,293.00 115.00 3,144.00
           
Earnings per Share - Basic 454.00¢ 384.00¢ 212.00¢ 8.00¢ 244.00¢
Earnings per Share - Adjusted 821.00¢ 726.00¢ 212.00¢ 8.00¢ 244.00¢
           
Dividend per Share 310.00¢ 290.00¢ 290.00¢ 287.00¢ 280.00¢
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Assets          
Non-Current Assets          
Property, Plant & Equipment 11,647.00 10,502.00 9,449.00 10,171.00 8,917.00
Intangible Assets 58,202.00 58,137.00 59,127.00 62,384.00 32,792.00
Other Non-Current Assets 6,277.00 5,521.00 4,172.00 5,327.00 4,329.00
  78,208.00 76,065.00 73,890.00 79,119.00 47,185.00
Current Assets          
Inventories 5,288.00 5,424.00 4,699.00 8,983.00 4,024.00
Cash at Bank & in Hand 5,488.00 5,840.00 6,166.00 6,329.00 7,832.00
Other Current Assets 2,079.00 1,664.00 87.00 556.00 666.00
  25,827.00 25,054.00 22,443.00 26,244.00 19,544.00
           
Other Assets n/a n/a 150.00 n/a n/a
Total Assets 104,035.00 101,119.00 96,483.00 105,363.00 66,729.00
Current Liabilities          
Borrowings 2,676.00 5,400.00 5,542.00 1,893.00 2,386.00
Other Current Liabilities 25,190.00 25,142.00 20,751.00 20,701.00 17,921.00
           
Current Liabilities 27,866.00 30,542.00 26,293.00 22,594.00 20,307.00
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Borrowings 27,619.00 23,222.00 23,690.00 28,888.00 17,994.00
Other Non-Current Liabilities 3,453.00 5,345.00 5,602.00 7,432.00 9,288.00
Non-Current Liabilities 35,298.00 31,411.00 33,132.00 43,482.00 30,784.00
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 63,164.00 61,953.00 59,425.00 66,076.00 51,091.00
           
Net Assets 40,871.00 39,166.00 37,058.00 39,287.00 15,638.00
           
Shareholders Funds 40,786.00 39,143.00 37,037.00 39,268.00 15,622.00
           
Minority Interests/Other Equity 85.00 23.00 21.00 19.00 16.00
Total Equity 40,871.00 39,166.00 37,058.00 39,287.00 15,638.00
Cash Flow 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Net Cash Flow From Operating Activities 11,861.00 10,345.00 9,808.00 5,963.00 4,799.00
Net Cash Flow from Investing Activities (7,980.00) (4,064.00) (2,960.00) (11,058.00) (285.00)
Net Cash Flow from Financing Activities (3,996.00) (6,567.00) (6,823.00) 3,649.00 (2,203.00)
Net Increase/Decrease In Cash (115.00) (286.00) 25.00 (1,446.00) 2,311.00
Ratios - based on IFRS 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
PE Ratio - Adjusted 17.3 19.8 72.1 1,471.2 40.9
PEG - Adjusted 1.3 0.1 0.0 n/a 0.3
Earnings per Share Growth - Adjusted 13% 242% 2,550% -97% 137%
Dividend Cover 2.65 2.50 0.73 0.03 0.87
Revenue per Share 3,459.57¢ 2,932.84¢ 2,865.05¢ 2,638.72¢ 2,028.73¢
Pre-Tax Profit per Share 556.05¢ 441.68¢ 161.56¢ (18.69¢) 298.48¢
Operating Margin 18.50% 17.88% 8.47% 2.82% 19.39%
Return on Capital Employed 58.03% 65.47% 34.10% 6.68% 76.32%
           
Dividend Yield 2.2% 2.0% 1.9% 2.4% 2.8%
Dividend per Share Growth 6.90% n/a 1.05% 2.50% n/a
Operating Cash Flow per Share 758.86¢ 662.29¢ 633.59¢ 420.52¢ 365.78¢
Cash Incr/Decr per Share (7.36¢) (18.31¢) 1.61¢ (101.97¢) 176.14¢
Net Asset Value per Share (exc. Intangibles) (1,108.83¢) (1,214.53¢) (1,425.65¢) (1,628.84¢) (1,307.47¢)
Net Gearing 60.82% 58.20% 62.28% 62.27% 80.32%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Top of Page